Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Coronary Access After Evolut FX Plus TAVI: Impact of Commissural Alignment and the Large-Cell Frame Design: ACCESS-FX+ Registry

NCT07813273 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.

NCT NCT07813273
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07813273 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Coronary Access After Evolut FX Plus TAVI: Impact of Commissural Alignment and the Large-Cell Frame Design: ACCESS-FX+ Registry
Lead sponsor
Yonsei University
Phase
Observational
Overall status
Not yet recruiting
Start date
September 29, 2026
Completion date
March 31, 2029
Enrollment
122 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

severe aortic stenosis